Enfuvirtide Resistance Mutations: Impact on Human Immunodeficiency Virus Envelope Function, Entry Inhibitor Sensitivity, and Virus Neutralization

Enfuvirtide (ENF/T-20/Fuzeon), the first human immunodeficiency virus (HIV) entry inhibitor to be licensed, targets a structural intermediate of the entry process. ENF binds the HR1 domain in gp41 after Env has bound CD4, preventing conformational changes needed for membrane fusion. Mutations in HR1...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Reeves, Jacqueline D., Lee, Fang-Hua, Miamidian, John L., Jabara, Cassandra B., Juntilla, Marisa M., Doms, Robert W.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2005
Assuntos:
Vaccines and Antiviral Agents
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1069568/
https://ncbi.nlm.nih.gov/pubmed/15795284
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.79.8.4991-4999.2005
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados